Bellecapital International Ltd. acquired a new stake in TriMas Co. (NASDAQ:TRS - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 1,185,855 shares of the industrial products company's stock, valued at approximately $29,160,000. TriMas makes up 5.2% of Bellecapital International Ltd.'s portfolio, making the stock its 2nd biggest holding. Bellecapital International Ltd. owned 2.92% of TriMas at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of the stock. Impax Asset Management Group plc lifted its position in TriMas by 216.4% in the 3rd quarter. Impax Asset Management Group plc now owns 410,000 shares of the industrial products company's stock valued at $10,467,000 after acquiring an additional 280,431 shares in the last quarter. State of New Jersey Common Pension Fund D increased its stake in TriMas by 8.6% in the 3rd quarter. State of New Jersey Common Pension Fund D now owns 79,822 shares of the industrial products company's stock valued at $2,038,000 after buying an additional 6,344 shares during the last quarter. Sasco Capital Inc. CT increased its stake in TriMas by 26.6% in the 3rd quarter. Sasco Capital Inc. CT now owns 44,980 shares of the industrial products company's stock valued at $1,148,000 after buying an additional 9,460 shares during the last quarter. Intech Investment Management LLC bought a new position in shares of TriMas during the 3rd quarter worth approximately $269,000. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of TriMas by 0.9% in the third quarter. Charles Schwab Investment Management Inc. now owns 582,846 shares of the industrial products company's stock valued at $14,880,000 after acquiring an additional 4,977 shares in the last quarter. Institutional investors and hedge funds own 99.42% of the company's stock.
Analysts Set New Price Targets
TRS has been the subject of several research analyst reports. BWS Financial reaffirmed a "buy" rating and set a $40.00 target price on shares of TriMas in a research report on Friday. StockNews.com upgraded shares of TriMas from a "sell" rating to a "hold" rating in a research note on Wednesday, November 13th.
Read Our Latest Stock Analysis on TRS
TriMas Stock Performance
Shares of TRS traded up $0.33 during mid-day trading on Monday, hitting $20.82. The stock had a trading volume of 274,670 shares, compared to its average volume of 264,742. TriMas Co. has a 52 week low of $19.33 and a 52 week high of $28.51. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44. The business has a fifty day moving average price of $23.78 and a 200-day moving average price of $25.12. The firm has a market cap of $844.71 million, a P/E ratio of 32.48 and a beta of 0.66.
TriMas Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 7th. Shareholders of record on Friday, February 28th will be issued a dividend of $0.04 per share. This represents a $0.16 annualized dividend and a yield of 0.77%. The ex-dividend date of this dividend is Friday, February 28th. TriMas's dividend payout ratio (DPR) is presently 25.00%.
TriMas Profile
(
Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Further Reading

Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.